Bifidobacterium Longum: Protection against Inflammatory Bowel Disease

The prevalence of inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn’s disease (CD), increases gradually worldwide in the past decades. IBD is generally associated with the change of the immune system and gut microbiota, and the conventional treatments usually result...

Full description

Saved in:
Bibliographic Details
Main Authors: Shunyu Yao, Zixi Zhao, Weijun Wang, Xiaolu Liu
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2021/8030297
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849308277098151936
author Shunyu Yao
Zixi Zhao
Weijun Wang
Xiaolu Liu
author_facet Shunyu Yao
Zixi Zhao
Weijun Wang
Xiaolu Liu
author_sort Shunyu Yao
collection DOAJ
description The prevalence of inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn’s disease (CD), increases gradually worldwide in the past decades. IBD is generally associated with the change of the immune system and gut microbiota, and the conventional treatments usually result in some side effects. Bifidobacterium longum, as colonizing bacteria in the intestine, has been demonstrated to be capable of relieving colitis in mice and can be employed as an alternative or auxiliary way for treating IBD. Here, the mechanisms of the Bifidobacterium longum in the treatment of IBD were summarized based on previous cell and animal studies and clinical trials testing bacterial therapies. This review will be served as a basis for future research on IBD treatment.
format Article
id doaj-art-14af4595fdb044f89efc9cc685cdbf42
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-14af4595fdb044f89efc9cc685cdbf422025-08-20T03:54:29ZengWileyJournal of Immunology Research2314-88612314-71562021-01-01202110.1155/2021/80302978030297Bifidobacterium Longum: Protection against Inflammatory Bowel DiseaseShunyu Yao0Zixi Zhao1Weijun Wang2Xiaolu Liu3School of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, ChinaSchool of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, ChinaSchool of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, ChinaSchool of Chemistry and Biological Engineering, University of Science and Technology Beijing, Beijing 100083, ChinaThe prevalence of inflammatory bowel disease (IBD), which includes ulcerative colitis (UC) and Crohn’s disease (CD), increases gradually worldwide in the past decades. IBD is generally associated with the change of the immune system and gut microbiota, and the conventional treatments usually result in some side effects. Bifidobacterium longum, as colonizing bacteria in the intestine, has been demonstrated to be capable of relieving colitis in mice and can be employed as an alternative or auxiliary way for treating IBD. Here, the mechanisms of the Bifidobacterium longum in the treatment of IBD were summarized based on previous cell and animal studies and clinical trials testing bacterial therapies. This review will be served as a basis for future research on IBD treatment.http://dx.doi.org/10.1155/2021/8030297
spellingShingle Shunyu Yao
Zixi Zhao
Weijun Wang
Xiaolu Liu
Bifidobacterium Longum: Protection against Inflammatory Bowel Disease
Journal of Immunology Research
title Bifidobacterium Longum: Protection against Inflammatory Bowel Disease
title_full Bifidobacterium Longum: Protection against Inflammatory Bowel Disease
title_fullStr Bifidobacterium Longum: Protection against Inflammatory Bowel Disease
title_full_unstemmed Bifidobacterium Longum: Protection against Inflammatory Bowel Disease
title_short Bifidobacterium Longum: Protection against Inflammatory Bowel Disease
title_sort bifidobacterium longum protection against inflammatory bowel disease
url http://dx.doi.org/10.1155/2021/8030297
work_keys_str_mv AT shunyuyao bifidobacteriumlongumprotectionagainstinflammatoryboweldisease
AT zixizhao bifidobacteriumlongumprotectionagainstinflammatoryboweldisease
AT weijunwang bifidobacteriumlongumprotectionagainstinflammatoryboweldisease
AT xiaoluliu bifidobacteriumlongumprotectionagainstinflammatoryboweldisease